Clinical Trials · NCT07668414
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 650
- Start date
- Sep 2026
- Locations
- 43 sites, United States
- Primary endpoint
- Relative change in body weight